Animal Models of Ebolavirus Infection.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Comparative medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  PMID 28662754PMCID PMC5482517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo Ebola virus infection leads to a strong innate response in circulating immune cells

  2016cited by this paper
• Adapted Lethality: What We Can Learn from Guinea Pig-Adapted Ebola Virus Infection Model

  2016cited by this paper
• Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

  2016cited by this paper
• Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease.

  2016cited by this paper
• Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges

  2016cited by this paper
• An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted With Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models.

  2016cited by this paper
• A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

  2016cited by this paper
• Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus

  2016cited by this paper
• Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.

  2016cited by this paper
• Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

  2016cited by this paper
• Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial

  2016cited by this paper
• Humanized Mice--A Neoteric Animal Disease Model for Ebola Virus?

  2016cited by this paper
• Transmission of Ebola Viruses: What We Know and What We Do Not Know

  2015cited by this paper
• Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.

  2015cited by this paper
• Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.

  2015cited by this paper
• Lipid nanoparticle siRNA treatment of Ebola virus Makona infected nonhuman primates

  2015cited by this paper
• Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.

  2015cited by this paper
• Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles

  2015cited by this paper
• Adenovirus-vectored Ebola vaccines

  2015cited by this paper
• Ebola virus disease and the veterinary perspective

  2015cited by this paper
• Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig.

  2015cited by this paper
• Ebola Virus Disease in Mice with Transplanted Human Hematopoietic Stem Cells

  2015cited by this paper
• Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges

  2015cited by this paper
• STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control

  2015cited by this paper
• Characterization of Clinical and Immunological Parameters During Ebola Virus Infection of Rhesus Macaques

  2015cited by this paper
• Animal models for ebolavirus countermeasures discovery: what defines a useful model?

  2015cited by this paper
• Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

  2015cited by this paper
• Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013

  2014cited by this paper
• Efficient Gene Targeting in Golden Syrian Hamsters by the CRISPR/Cas9 System

  2014cited by this paper
• Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory

  2014cited by this paper
• Structures of protective antibodies reveal sites of vulnerability on Ebola virus

  2014cited by this paper
• Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™

  2014cited by this paper
• Advances in marmoset and mouse models buoy Ebola research

  2014cited by this paper
• Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance

  2014cited by this paper
• Vaccinating captive chimpanzees to save wild chimpanzees

  2014cited by this paper
• A Syrian golden hamster model recapitulating ebola hemorrhagic fever.

  2013cited by this paper
• Animal models for Ebola and Marburg virus infections

  2013cited by this paper
• Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine

  2013cited by this paper
• Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus

  2013cited by this paper
• Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolution

  2012cited by this paper
• The Baboon (Papio spp.) as a Model of Human Ebola Virus Infection

  2012cited by this paper
• Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.

  2012cited by this paper
• Transmission of Ebola virus from pigs to non-human primates

  2012cited by this paper
• Ten Years of the Collaborative Cross

  2012cited by this paper
• Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

  2012cited by this paper
• Use of the Syrian Hamster as a New Model of Ebola Virus Disease and Other Viral Hemorrhagic Fevers

  2012cited by this paper
• A small nonhuman primate model for filovirus-induced disease

  2011cited by this paper
• Assessment of rodents as animal models for Reston ebolavirus.

  2011cited by this paper
• Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.

  2011cited by this paper
• Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.

  2011cited by this paper
• Filovirus infection of STAT-1 knockout mice.

  2011cited by this paper
• Advances in virus-like particle vaccines for filoviruses.

  2011cited by this paper
• Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

  2010cited by this paper
• Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription.

  2010cited by this paper
• Disease modeling for Ebola and Marburg viruses

  2009cited by this paper
• Mechanisms and Consequences of Ebolavirus-Induced Lymphocyte Apoptosis

  2009cited by this paper
• Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007

  2009cited by this paper
• Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.

  2009cited by this paper
• Evasion of Interferon Responses by Ebola and Marburg Viruses

  2009cited by this paper
• Drug targets in infections with Ebola and Marburg viruses.

  2009cited by this paper
• Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever

  2009cited by this paper
• Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

  2007cited by this paper
• The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing

  2007cited by this paper
• Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

  2007cited by this paper
• Lymphocyte death in a mouse model of Ebola virus infection.

  2007cited by this paper
• The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics

  2007cited by this paper
• Baboon as a nonhuman primate model for vaccine studies.

  2006cited by this paper
• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

  2005cited by this paper
• Demand for Nonhuman Primate Resources in the Age of Biodefense

  2005cited by this paper
• A serological survey of Ebola virus infection in central African nonhuman primates.

  2004cited by this paper
• Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

  2003cited by this paper
• Ebola Virus Pathogenesis: Implications for Vaccines and Therapies

  2003cited by this paper
• Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

  2003cited by this paper
• Ebola virus: from discovery to vaccine

  2003cited by this paper
• Emergence and re-emergence of vesicular stomatitis in the United States.

  2002cited by this paper
• Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody

  2002cited by this paper
• Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.

  2001cited by this paper
• The role of the Type I interferon response in the resistance of mice to filovirus infection.

  2001cited by this paper
• Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus.

  2001cited by this paper
• Development of a preventive vaccine for Ebola virus infection in primates

  2000cited by this paper
• Immune and pathophysiological processes in baboons experimentally infected with Ebola virus adapted to guinea pigs.

  2000cited by this paper
• Characterization of the L gene and 5' trailer region of Ebola virus.

  1999cited by this paper
• Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections.

  1999cited by this paper
• Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.

  1999cited by this paper
• Animal pathology of filoviral infections.

  1999cited by this paper
• An analysis of features of pathogenesis in two animal models of Ebola virus infection.

  1999cited by this paper
• Experimental filovirus infections.

  1999cited by this paper
• A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

  1998cited by this paper
• Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.

  1997cited by this paper
• Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure.

  1996cited by this paper
• [Attempts to develop a vaccine against Ebola fever].

  1995cited by this paper
• [Experimental study of Ebola hemorrhagic fever in baboon models].

  1995cited by this paper
• Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.

  1995cited by this paper
• [Preparation of hyperimmune horse serum against Ebola virus].

  1995cited by this paper
• [The evaluation in hamadryas baboons of the possibility for the specific prevention of Ebola fever].

  1994cited by this paper
• Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.

  1994cited by this paper
• Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain.

  1992cited by this paper
• Ebola haemorrhagic fever in Zaire, 1976.

  1978cited by this paper
• Ebola haemorrhagic fever: experimental infection of monkeys.

  1978cited by this paper

• Efficacy evaluation of the S-adenosylhomocysteine hydrolase inhibitor MSD-914 in rhesus macaques (Macaca Mulatta) challenged with Ebola virus by the intramuscular route

  2026cites this paper
• Deep sequencing of serially passaged Sudan virus in guinea pigs uncovers adaptive mutations

  2025cites this paper
• Ebola virus’ hidden target: virus transmission to and infection of skin

  2025cites this paper
• Single-cycle, pseudotyped reporter influenza virus to facilitate evaluation of treatment strategies for avian influenza, Ebola and other highly infectious diseases in vivo

  2025cites this paper
• Development of a Pentacistronic Ebola Virus Minigenome System

  2025cites this paper
• [Non-alphabetic viral hepatitis].

  2025cites this paper
• Establishment and application of a surrogate model for human Ebola virus disease in BSL-2 laboratory.

  2024cites this paper
• A Review of Nonhuman Primate Models of Rift Valley Fever Virus Infection: Progress, Challenge Strains, and Future Directions

  2024cites this paper
• Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse

  2024cites this paper
• Development of rhesus macaque astrocyte cell lines supporting infection with a panel of viruses

  2024cites this paper
• Mapping of susceptibility loci for Ebola virus pathogenesis in mice

  2024cites this paper
• Marmosets as models of infectious diseases

  2024cites this paper
• Development and Clinical Evaluation of a Rapid Point of Care Test for Ebola Virus Infection in Humans

  2023cites this paper
• Utilizing non‐human primate models to combat recent COVID‐19/SARS‐CoV‐2 and viral infectious disease outbreaks

  2023cites this paper
• Analysis of the Ability to Skill Formation and Stability of the Formed Skill in Mature Male Rhesus Monkeys (Macaca mulatta) and Hamadryas Baboons (Papio hamadryas)

  2023cites this paper
• Pathogenicity of Lloviu and Bombali viruses in IFNAR-/- mice.

  2023cites this paper
• Magnetic Resonance Imaging for Monitoring of Hepatic Disease Induced by Ebola Virus: a Nonhuman Primate Proof-of-Concept Study

  2023cites this paper
• Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteins

  2023cites this paper
• Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques

  2023cites this paper
• Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

  2023cites this paper
• Development of immortalized rhesus macaque kidney cells supporting infection with a panel of viruses

  2023cites this paper
• Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

  2022cites this paper
• Study the Differences between the Parameters of Learning and Exploratory Activities in Adult Male Rhesus Monkeys (Macaca mulatta) and Baboon Hamadryas (Papio hamadryas)

  2022cites this paper
• Bridging Animal and Human Data in Pursuit of Vaccine Licensure

  2022cites this paper
• The Prophylactic and Therapeutic Efficacy of the Broadly Active Antiviral Ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a Mouse Model of Lethal Ebola Virus Infection

  2022cites this paper
• Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection

  2022cites this paper
• Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs

  2022cites this paper
• Computational Study on Potential Novel Anti-Ebola Virus Protein VP35 Natural Compounds

  2021cites this paper
• Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection

  2021cites this paper
• Transcriptomic Analysis Reveals Host miRNAs Correlated with Immune Gene Dysregulation during Fatal Disease Progression in the Ebola Virus Cynomolgus Macaque Disease Model

  2021cites this paper
• Mucosal Challenge Ferret Models of Ebola Virus Disease

  2021cites this paper
• Development of Pandemic Vaccines: ERVEBO Case Study

  2021cites this paper
• Development of a Well-Characterized Rhesus Macaque Model of Ebola Virus Disease for Support of Product Development

  2021cites this paper
• Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection

  2021cites this paper
• The era of gene therapy: from preclinical development to clinical application.

  2021cites this paper
• Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates

  2021cites this paper
• Modulation of immune response in Ebola virus disease.

  2021cites this paper
• Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model

  2021cites this paper
• COVID-19 and Animal-Based Research.

  2021cites this paper
• A Review of Murine Cytomegalovirus as a Model for Human Cytomegalovirus Disease—Do Mice Lie?

  2020cites this paper
• Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

  2020cites this paper
• Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics

  2020cites this paper
• Ebola Virus Dose Response Model for Aerosolized Exposures: Insights from Primate Data

  2020cites this paper
• Cranial Vena Cava Syndrome in Guinea Pigs with Chronic Jugular Vein Catheters.

  2020cites this paper
• Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir

  2019cites this paper
• Syrian Hamster as an Animal Model for the Study on Infectious Diseases

  2019cites this paper
• Pulmonary Involvement during the Ebola Virus Disease

  2019cites this paper
• Ebola Patient Virus Cycle Threshold and Risk of Household Transmission of Ebola Virus.

  2019cites this paper
• Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus

  2019cites this paper
• The Collaborative Cross: A Systems Genetics Resource for Studying Host-Pathogen Interactions

  2019cites this paper
• Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases.

  2019cites this paper
• Ebola Virus: Pathogenesis and Countermeasure Development.

  2019cites this paper
• A VP35 Mutant Ebola Virus Lacks Virulence but Can Elicit Protective Immunity to Wild-Type Virus Challenge.

  2019cites this paper
• Equine-Origin Immunoglobulin Fragments Protect Nonhuman Primates from Ebola Virus Disease

  2018cites this paper
• Special Issue: Infectious Disease Research: Animal Models and Risk Management.

  2017cites this paper
• Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC).

  2017cites this paper